Tag Archives: innovation

Biotech Remains Strong in Florida

FLbiotech-thumb

Florida has always attracted visionaries – from Walt Disney to Kennedy Space Center. The ambition of great men helped transform inhospitable swamps into engines of the economy. However, with no income tax, and a large retiree population, Florida’s revenue long depended on booming tourism and the sales tax revenue it brought in. In the 1990’s, Florida’s leaders began to change that. Enterprise Florida was born. This public/private partnership was designed to identify and provide incentives Read More >

Public Policy  |  1 Comment  |  Email This Post
Tags: , , , ,

BioFlorida Conference: Here’s What You Missed

Isaac Ro, Goldman Sachs

As I mentioned last week, BIO President & CEO James C. Greenwood kicked-off  this week’s BioFlorida 14th Annual Conference with a keynote speech. Thanks to @BioFlorida2011 for tweeting some of his speech highlights. If you were not able to make it to Tampa for the conference, fear not, I’ve got you covered. Here’s a rundown of some of the things you missed: It’s All About Efficiency, Innovation and Globalization Goldman Sachs equity analyst Isaac Ro Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

BioCentury TV at BIO International Convention

marq_080711_play

BioCentury TV interviewed biotech leaders throughout the recent BIO International Convention in Washington, DC. The first interview can be found here (links to the other interviews can be found on the right). (July 24) Public+Private Part 1 — Turning Great Science into Medicine — and Jobs: Dr. Michel Goldman of Europe’s Innovative Medicines Initiative xplains how the pharma-driven agenda is creating a new “ecosystem” in Europe for drug developers. (July 31) Public+Private Part 2 – Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Bayh Dole Act a failure?

By Guest Writer Joseph Allen One hotly debated topic in Washington of real importance to the biotechnology community is how well the annual multi-billion dollar federal investment in R&D is being translated into new products, jobs and companies needed to improve the lives of US taxpayers and help pull the US economy out of its current doldrums.  An interesting insight on the debate is captured in a Washington Post article “Innovation’s golden opportunity” that ran Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , ,

Banning Gene Patents Will Promote Innovation?

Hampton Roads Partnership

Abolishing gene patents will deter, not promote, innovation, as the patent eligibility of isolated DNA molecules provides incentives necessary for development of life-enhancing diagnostics and therapeutics. R&D to identify genes, their sequences, genetic variations, and their disease  correlation is very costly. Claims like those of the patents at issue in the Myriad Genetics lawsuit have been a key foundation supporting the massive investment of time and capital that is necessary to bring life-enhancing DNA-based diagnostics Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,